Bio-Path Holdings (NASDAQ: BPTH) Stock Surges on Positive Phase 2 Study Results for AML Treatment
Bio-Path Holdings (NASDAQ: BPTH) stock soared during intraday trading Monday after the company announced promising interim results from its Phase […]
Bio-Path Holdings (NASDAQ: BPTH) stock soared during intraday trading Monday after the company announced promising interim results from its Phase […]